Cargando…
Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy.
We have defined a novel ovarian cancer-associated membrane antigen, 14C1, using human monoclonal antibodies derived by EBV-transformation of in situ sensitised patients' B-cells. The pattern of recognition of this antigen by these antibodies suggests that at least three epitopes are discernable...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977296/ https://www.ncbi.nlm.nih.gov/pubmed/1713052 |
_version_ | 1782135231366561792 |
---|---|
author | Gallagher, G. al-Azzawi, F. Walsh, L. P. Wilson, G. Handley, J. |
author_facet | Gallagher, G. al-Azzawi, F. Walsh, L. P. Wilson, G. Handley, J. |
author_sort | Gallagher, G. |
collection | PubMed |
description | We have defined a novel ovarian cancer-associated membrane antigen, 14C1, using human monoclonal antibodies derived by EBV-transformation of in situ sensitised patients' B-cells. The pattern of recognition of this antigen by these antibodies suggests that at least three epitopes are discernable. These antibodies can be used to promote the in vitro killing of ovarian cancer cells by activated macrophages and cytokines, implying a role for this antigen in the immunotherapy of ovarian malignancies. Evidence is presented that the 14C1 antigen may have some transmembrane signalling function. IMAGES: |
format | Text |
id | pubmed-1977296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1991 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19772962009-09-10 Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy. Gallagher, G. al-Azzawi, F. Walsh, L. P. Wilson, G. Handley, J. Br J Cancer Research Article We have defined a novel ovarian cancer-associated membrane antigen, 14C1, using human monoclonal antibodies derived by EBV-transformation of in situ sensitised patients' B-cells. The pattern of recognition of this antigen by these antibodies suggests that at least three epitopes are discernable. These antibodies can be used to promote the in vitro killing of ovarian cancer cells by activated macrophages and cytokines, implying a role for this antigen in the immunotherapy of ovarian malignancies. Evidence is presented that the 14C1 antigen may have some transmembrane signalling function. IMAGES: Nature Publishing Group 1991-07 /pmc/articles/PMC1977296/ /pubmed/1713052 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Gallagher, G. al-Azzawi, F. Walsh, L. P. Wilson, G. Handley, J. Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy. |
title | Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy. |
title_full | Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy. |
title_fullStr | Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy. |
title_full_unstemmed | Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy. |
title_short | Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy. |
title_sort | multiple epitopes of the human ovarian cancer antigen 14c1 recognised by human igg antibodies: their potential in immunotherapy. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977296/ https://www.ncbi.nlm.nih.gov/pubmed/1713052 |
work_keys_str_mv | AT gallagherg multipleepitopesofthehumanovariancancerantigen14c1recognisedbyhumaniggantibodiestheirpotentialinimmunotherapy AT alazzawif multipleepitopesofthehumanovariancancerantigen14c1recognisedbyhumaniggantibodiestheirpotentialinimmunotherapy AT walshlp multipleepitopesofthehumanovariancancerantigen14c1recognisedbyhumaniggantibodiestheirpotentialinimmunotherapy AT wilsong multipleepitopesofthehumanovariancancerantigen14c1recognisedbyhumaniggantibodiestheirpotentialinimmunotherapy AT handleyj multipleepitopesofthehumanovariancancerantigen14c1recognisedbyhumaniggantibodiestheirpotentialinimmunotherapy |